Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Clinical Chemistry|September 1, 1996
Hormonal and genetic analysis of a patient with congenital adrenal hyperplasiaR H Summers, D A Herold, B L SeelyAmerican Journal of Human Genetics|July 1, 1984
Localized chromosomal mosaicism as a cause of dysmorphic developmentJ R Seely, B L Seely, R Bley, et al.Investigative Ophthalmology & Visual Science|May 1, 1993
Stimulation of DNA synthesis and c-fos expression in corneal endothelium by insulin or insulin-like growth factor-IS T Feldman, D Gately, B L Seely, et al.Endocrinology|April 1, 1995
A functional assessment of insulin/insulin-like growth factor-I hybrid receptorsB L Seely, D R Reichart, Y Takata, et al.The Journal of Biological Chemistry|September 15, 1991
Tyrosine kinase-defective insulin receptors undergo insulin-induced microaggregation but do not concentrate in coated pitsR M Smith, B L Seely, N Shah, et al.Cancer Research|March 27, 1998
Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancerJ L Resnik, D B Reichart, K Huey, et al.Biochemical and Molecular Medicine|January 27, 1998
Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoterN J Webster, Y Kong, P Sharma, et al.Cancer Research|June 15, 1996
Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancerN J Webster, J L Resnik, D B Reichart, et al.Molecular and Cellular Biology|November 1, 1994
Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expressionB H Jhun, D W Rose, B L Seely, et al.The Journal of Biological Chemistry|November 4, 1994
Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAPP A Staubs, D R Reichart, A R Saltiel, et al.Pageof 2